Bruker Corp (NASDAQ: BRKR) has a higher price-to-earnings ratio of 62.34x compared to its average ratio, The 36-month beta value for BRKR is at 1.15. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 3 rating it as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for BRKR is 102.96M, and currently, shorts hold a 4.47% of that float. The average trading volume for BRKR on March 05, 2025 was 1.56M shares.
BRKR) stock’s latest price update
Bruker Corp (NASDAQ: BRKR)’s stock price has plunge by 1.98relation to previous closing price of 46.42. Nevertheless, the company has seen a -6.26% plunge in its stock price over the last five trading sessions. businesswire.com reported 2025-02-27 that KONTICH, Belgium–(BUSINESS WIRE)—- $BRKR #BRKR–Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative benchtop XRM system offers advanced capabilities comparable to larger, floor-standing systems to make high-resolution 3D X-ray microscopy accessible for demanding XRM applications in industrial applications and scientific research. The X4 POSEIDON features a high-end X-ray.
BRKR’s Market Performance
Bruker Corp (BRKR) has seen a -6.26% fall in stock performance for the week, with a -16.52% decline in the past month and a -18.31% plunge in the past quarter. The volatility ratio for the week is 4.16%, and the volatility levels for the past 30 days are at 4.38% for BRKR. The simple moving average for the past 20 days is -7.04% for BRKR’s stock, with a -22.87% simple moving average for the past 200 days.
Analysts’ Opinion of BRKR
Many brokerage firms have already submitted their reports for BRKR stocks, with Guggenheim repeating the rating for BRKR by listing it as a “Buy.” The predicted price for BRKR in the upcoming period, according to Guggenheim is $72 based on the research report published on December 19, 2024 of the previous year 2024.
UBS, on the other hand, stated in their research note that they expect to see BRKR reach a price target of $66. The rating they have provided for BRKR stocks is “Neutral” according to the report published on December 10th, 2024.
Goldman gave a rating of “Neutral” to BRKR, setting the target price at $60 in the report published on December 05th of the previous year.
BRKR Trading at -14.56% from the 50-Day Moving Average
After a stumble in the market that brought BRKR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.09% of loss for the given period.
Volatility was left at 4.38%, however, over the last 30 days, the volatility rate increased by 4.16%, as shares sank -16.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.71% lower at present.
During the last 5 trading sessions, BRKR fell by -6.47%, which changed the moving average for the period of 200-days by -39.06% in comparison to the 20-day moving average, which settled at $50.92. In addition, Bruker Corp saw -19.24% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BRKR starting from LAUKIEN FRANK H, who purchase 20,000 shares at the price of $50.92 back on Feb 18 ’25. After this action, LAUKIEN FRANK H now owns 38,459,563 shares of Bruker Corp, valued at $1,018,330 using the latest closing price.
PACKER RICHARD A, the Director of Bruker Corp, sale 3,350 shares at $57.82 during a trade that took place back on Dec 02 ’24, which means that PACKER RICHARD A is holding 80,904 shares at $193,683 based on the most recent closing price.
Stock Fundamentals for BRKR
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 0.49 for the gross margin
The net margin for Bruker Corp stands at 0.03. The total capital return value is set at 0.06. Equity return is now at value 7.16, with 2.25 for asset returns.
Based on Bruker Corp (BRKR), the company’s capital structure generated 0.54 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 1.17. The interest coverage ratio of the stock is 11.22.
Currently, EBITDA for the company is 253.1 million with net debt to EBITDA at 4.43. When we switch over and look at the enterprise to sales, we see a ratio of 2.69. The receivables turnover for the company is 6.01for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.60.
Conclusion
In conclusion, Bruker Corp (BRKR) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
